Serologicals (NASDAQ:SERO)
Historical Stock Chart
From Oct 2019 to Oct 2024
Serologicals Corporation (NASDAQ:SERO) announced today
that it will release its second quarter earnings on Wednesday, July
27, 2005 after the close of regular trading hours, and then host a
conference call on Thursday, July 28, 2005 at 9:00 a.m. (ET) to review
the results.
The conference call dial in number is 888-291-9234, International
dial-in 617-614-3923, confirmation code 67045571. The live broadcast
will also be available online at the Company's website at
www.serologicals.com and at www.StreetEvents.com.
If you are unable to participate in the call, a 14-day playback
will start July 28, 2005 at 11:00 a.m. (Eastern Time). To listen to
the playback, please call 888-286-8010, International dial-in
617-801-6888, and enter access code 14006006, or access the archived
web cast on the Company's website at www.serologicals.com.
Serologicals Corporation (NASDAQ:SERO), headquartered in Atlanta,
GA., is a global leader in developing and commercializing consumable
biological products, enabling technologies and services in support of
biological research, drug discovery, and the bioprocessing of life-
enhancing products. Our customers include researchers at major life
science companies and leading research institutions involved in key
disciplines, such as neurology, oncology, hematology, immunology,
cardiology, proteomics, infectious diseases, cell signaling and stem
cell research. In addition, Serologicals is the world's leading
provider of monoclonal antibodies for the blood typing industry.
Serologicals employs a total of more than 1,000 people worldwide
in three Serologicals' companies: Chemicon International,
headquartered in Temecula, CA, Upstate Group, LLC, headquartered in
Charlottesville, VA. and Celliance Corporation, headquartered in
Atlanta, GA. Serologicals is a registered trademark of Serologicals
Investment Company.